News for Syros Pharmaceuticals Stock (SYRS)

Bronstein, Gewirtz and Grossman, LLC Initiates an Investigation into Allegations Against Syros Pharmaceuticals, Inc. (SYRS) And Encourages Stockholders to Reach Out

Accesswire • 09/04/24

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged

PRNewsWire • 09/03/24

Syros Pharmaceuticals Inc. Is Being Inquired Into For Possibly Violating Securities Laws And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/03/24

Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Syros Pharmaceuticals, Inc. (SYRS) and Encourages Stockholders to Seek Compensation for Alleged Wrongdoings

Accesswire • 09/03/24

The Schall Law Firm Invites Public Participation In An Investigation Into Whether Syros Pharmaceuticals Inc Committed Securities Fraud

Accesswire • 09/02/24

Bronstein, Gewirtz and Grossman, LLC Initiates an Investigation into Allegations Against Syros Pharmaceuticals, Inc. (SYRS) And Encourages Investors to Reach Out

Accesswire • 09/02/24

Syros Pharmaceuticals Inc. May Have Infringed On Shareholders' Rights And Those With Losses Are Urged To Contact The Schall Law Firm

Accesswire • 09/01/24

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Investors to Inquire about Securities Investigation

Accesswire • 09/01/24

The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals Is Liable To Stockholders For Breaking Securities Laws And The Firm Wants The Public's Help

Accesswire • 08/30/24

Individuals With Losses In Syros Pharmaceuticals Inc. Should Join The Schall Law Firm In An Inquiry Into Possible Securities Law Violations

Accesswire • 08/30/24

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Shareholders to Inquire about Securities Investigation

Accesswire • 08/30/24

Stockholders In Syros Pharmaceutical Inc. Are Invited To Join The Schall Law Firm In An Inquiry About Possible Securities Law Infractions

Accesswire • 08/29/24

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Stockholders to Inquire about Securities Investigation

Accesswire • 08/29/24

Syros Pharmaceuticals Being Investigated on Behalf of Syros Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details.

Accesswire • 08/29/24

Syros Pharmaceutical Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Reach Out

Accesswire • 08/28/24

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Accesswire • 08/28/24

SYRS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Syros Pharmaceuticals, Inc. Shareholders Who Lost Money

Accesswire • 08/28/24

The Schall Law Firm Is Looking Into Syros Pharmaceuticals Inc's Potential Violations Of Securities Laws And Investors Are Invited To Contribute

Accesswire • 08/27/24

Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Syros Pharmaceuticals, Inc. (SYRS) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings

Accesswire • 08/27/24

Shareholders that lost money on Syros Pharmaceuticals, Inc.(SYRS) should contact Levi & Korsinsky about Securities Fraud Investigation - SYRS

Accesswire • 08/27/24

Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences

Business Wire • 08/27/24

A Securities Fraud Inquiry Has Been Opened Into Syros Pharmaceuticals Inc And The Schall Law Firm Wants Stockholders To Join

Accesswire • 08/26/24

Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Syros Pharmaceuticals, Inc. (SYRS) and Encourages Investors to Seek Compensation for Alleged Wrongdoings

Accesswire • 08/26/24

Levi & Korsinsky Reminds Syros Pharmaceuticals Investors of the Ongoing Investigation into Potential Violations of Securities Laws - SYRS

Accesswire • 08/25/24

ATTENTION SYRS SHAREHOLDERS: Investors who lost money on Syros Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Accesswire • 08/25/24